Triple

T3767699
Position Surface form Disambiguated ID Type / Status
Subject Certificates of Suitability E82718 entity
Predicate basedOn P98 FINISHED
Object European Pharmacopoeia monographs E12899 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: European Pharmacopoeia monographs | Statement: [Certificates of Suitability, basedOn, European Pharmacopoeia monographs]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: European Pharmacopoeia monographs
Context triple: [Certificates of Suitability, basedOn, European Pharmacopoeia monographs]
  • A. European Union pharmaceutical legislation
    European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
  • B. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • C. European Directorate for the Quality of Medicines & HealthCare chosen
    The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
  • D. Committee for Herbal Medicinal Products
    The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
  • E. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ad8b207b0081909d2b48843fbd8795 completed March 8, 2026, 2:43 p.m.
NER Named-entity recognition batch_69adcc2bdf6c819088d3c6ace83ca5ea completed March 8, 2026, 7:21 p.m.
NED1 Entity disambiguation (via context triple) batch_69b4e5251d2481909f692937271a8013 completed March 14, 2026, 4:33 a.m.
Created at: March 8, 2026, 3:35 p.m.